医療レポート：Non-Small Cell Lung Cancer (NSCLC)-疫学予測（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 7
2.1 Catalyst 7
2.2 Upcoming Reports 7
3 Epidemiology 8
3.1 Risk Factors and Comorbidities 9
3.1.1 Smokers are more likely to have lung cancer than non-smokers 10
3.1.2 Long-term exposure to radon increases the risk of lung cancer 11
3.1.3 Family history of any cancer increases lung cancer risk 11
3.1.4 TB increases the risk of lung cancer and increases mortality risk 12
3.1.5 COPD is a comorbidity that reduces lung cancer survival 12
3.1.6 Lung cancer screening programs may not be beneficial 13
3.1.7 Stage at diagnosis significantly impacts the survival of lung cancer cases 14
3.2 Global Trends 14
3.2.1 US 18
3.2.2 France 22
3.2.3 Germany 24
3.2.4 Italy 25
3.2.5 Spain 27
3.2.6 UK 29
3.2.7 Japan 30
3.2.8 China 32
3.2.9 India 34
3.3 Forecast Methodology 35
3.3.1 Sources Used 37
3.3.2 Sources Not Used 41
3.3.3 Forecast Methods and Assumptions 42
3.4 Epidemiology Forecast (2012–2022) 44
3.4.1 Incident Cases of NSCLC 44
3.4.2 Age-Specific Incident Cases of NSCLC 46
3.4.3 Sex-Specific Incident Cases of NSCLC 47
3.4.4 Age-Standardized Incidence Rates of NSCLC 48
3.4.5 Segmentation of NSCLC Incident Cases 50
3.5 Discussion 58
3.5.1 Limitations of the Analysis 59
3.5.2 Strengths of the Analysis 59
4 Appendix 61
4.1 Bibliography 61
4.2 About the Authors 69
4.2.1 Epidemiologists 69
4.2.2 Reviewers 70
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis 71
4.2.4 Global Head of Healthcare 71
4.3 About GlobalData 72
4.4 About EpiCast 72
4.5 Contact Us 72
4.6 Disclaimer 73